GenixPharmaceucticals Corporation (GENX) — Cash Flow-to-Debt Ratio
GenixPharmaceucticals Corporation (GENX) has a Cash Flow-to-Debt Ratio of -0.02x as of January 2026, meaning its operating cash flow of CA$-30.25K could theoretically repay 0% of its total liabilities (CA$1.51 Million) in one year. See GenixPharmaceucticals Corporation free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
GenixPharmaceucticals Corporation Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for GenixPharmaceucticals Corporation across 11 annual periods. Also explore how fast is GenixPharmaceucticals Corporation growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for GenixPharmaceucticals Corporation (2015–2025)
Year-by-year debt coverage analysis for GenixPharmaceucticals Corporation. For market capitalisation and broader financial context, see GENX market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.08x | CA$-124.07K | CA$1.47 Million | ▲ +44.7% |
| 2024 | -0.15x | CA$-187.34K | CA$1.23 Million | ▲ +6.0% |
| 2023 | -0.16x | CA$-220.67K | CA$1.36 Million | ▲ +22.2% |
| 2022 | -0.21x | CA$-219.58K | CA$1.05 Million | ▲ +63.3% |
| 2021 | -0.57x | CA$-428.31K | CA$755.19K | ▼ -42.5% |
| 2020 | -0.40x | CA$-195.03K | CA$489.88K | ▲ +44.0% |
| 2019 | -0.71x | CA$-58.55K | CA$82.41K | ▼ -326.9% |
| 2018 | 0.31x | CA$34.18K | CA$109.15K | ▲ +1013.5% |
| 2017 | -0.03x | CA$-9.35K | CA$272.80K | ▲ +98.6% |
| 2016 | -2.43x | CA$-165.07K | CA$68.04K | ▲ +40.6% |
| 2015 | -4.09x | CA$-452.55K | CA$110.78K | — |